miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α

by Feng X, Liu N, Deng S, Zhang DD, Wang KX, Lu MS
Published 2017-12-01

Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer

by Seesaha PK, Wang KX, Wang GQ, Cui TY, Zhao FJ, Pan LL, Li XC, Shu YQ, Chen XF
Published 2021-03-01

Study on Efficacy and Safety of Low-Dose Apatinib Combined with Camrelizumab and SOX Regimen as First-Line Treatment of Locally Advanced and Unresectable Gastric/Gastroesophageal J...

by Wang KX, Cui TY, Yang XD, Wang GQ, Jiang QS, Sun H, Jiang NY, Yong XM, Shi CB, Ding YB, Chen XF, Fang YY
Published 2021-09-01